🚚  Free shipping over $140 — Canadian domestic, no customs Skip to content

How Much Bacteriostatic Water for IGF-1 LR3? Reconstitution Calculator

Concentration and syringe-unit draw math for reconstituted research solutions — for research use only, not medical or personal-dosing guidance.

Community conventionA commonly cited community/vendor convention, not trial-backed. Research use only.

Reconstitution calculator

Vial contents

Use the total mg printed on the vial label.

Diluent volume

More water = lower concentration — watch the vial in the results preview fill as you set it.

IGF-1 LR3 is conventionally reconstituted in 0.6% acetic acid rather than bacteriostatic water for stability. The concentration math is identical either way — this tool computes mass ÷ diluent volume regardless of the diluent used.

Target amount per draw

The amount of peptide each draw should contain.

Results preview

1 2 3
0 20 40 60 80 100

1 mL added · 33% full

Sizes only change the illustrations and scale labels — never the math.

Draw 0.2 units

= 0.00 mL on a 1.0 mL syringe (100 u)

Concentration

10.00 mg/mL

mg per mL of finished solution

10,000 mcg/mL

Dose per draw: 20 mcg (0.02 mg)

Draws per vial

500

full draws this vial yields at the target amount

IGF-1 LR3 reconstitution chart — bacteriostatic water to concentration

Resulting concentration (mg/mL) when a lyophilized IGF-1 LR3 vial is reconstituted with common bacteriostatic-water volumes, for research preparations. Add the diluent volume that reaches the mg/mL a research protocol specifies.

IGF-1 LR3 vial amount in milligrams versus bacteriostatic water volume in millilitres, showing the reconstituted concentration in mg/mL.
Vial amount+1 mL BAC water+2 mL BAC water+3 mL BAC water+5 mL BAC water
2 mg 2 mg/mL 1 mg/mL 0.67 mg/mL 0.4 mg/mL
5 mg 5 mg/mL 2.5 mg/mL 1.67 mg/mL 1 mg/mL
10 mg 10 mg/mL 5 mg/mL 3.33 mg/mL 2 mg/mL
15 mg 15 mg/mL 7.5 mg/mL 5 mg/mL 3 mg/mL

View the IGF-1 LR3 1mg product page

Frequently asked questions

How much reconstitution solution for 10 mg IGF-1 LR3?

For a 10 mg vial of IGF-1 LR3, the volume of bacteriostatic water added is what sets the concentration of the research preparation — the peptide mass itself does not change. Adding 1 mL of bacteriostatic water yields 10 mg/mL, 2 mL yields 5 mg/mL, and 3 mL yields 3.33 mg/mL. Choose the diluent volume that reaches the mg/mL a research protocol specifies, or enter any amount in the calculator above. Supplied for laboratory research use only.

How much bacteriostatic water do I add to 10 mg of IGF-1 LR3?

The amount of bacteriostatic water added to a 10 mg IGF-1 LR3 vial is selected to reach a target concentration for a research preparation. To yield 5 mg/mL, add 2 mL; to yield 10 mg/mL, add 1 mL. This calculator performs the concentration and volume arithmetic (mass ÷ diluent volume). It is a lab-math utility for research use only, not medical or dosing guidance.

What concentration does IGF-1 LR3 reach after reconstitution?

Concentration (mg/mL) equals the peptide mass in the vial divided by the volume of bacteriostatic water added. A 10 mg vial reconstituted with 2 mL of bacteriostatic water yields 5 mg/mL; with 1 mL it yields 10 mg/mL. The chart on this page lists common IGF-1 LR3 vial amounts against several bacteriostatic-water volumes so the resulting concentration can be read directly. For research use only.

Does adding more bacteriostatic water change how much IGF-1 LR3 is in the vial?

No. Adding bacteriostatic water changes the concentration (mg per mL), not the total mass of IGF-1 LR3 in the vial. More diluent produces a more dilute research solution that requires a larger measured volume for the same amount; less diluent produces a more concentrated solution requiring a smaller measured volume. This tool computes those figures for reconstituted research solutions only.

Browse every peptide reconstitution calculator

For research use only. Not medical guidance. Not for human consumption. This tool performs concentration and volume arithmetic for reconstituted research solutions and does not evaluate protocol design or subject safety.